Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Series D

PsiQuantum crosses off $450m in funding
PsiQuantum has become the first unicorn in Imec.xpand’s portfolio as it fetched a valuation of more than $3bn.
Form Energy recharges in $200m round
ArcelorMittal led a series D round for the rechargeable battery developer spun out of MIT.
Go1 inputs $200m in series D funding
The Oxford-backed corporate education resource provider’s overall funding now stands at more than $280m.
CMR Surgical seizes $600m
The surgical technology developer was valued at $3bn in a series C round backed by returning investor Cambridge Innovation Capital.
Celonis captures $1bn series D
TUM spinout Celonis has grown to Germany’s first decacorn, three years after becoming the university’s first unicorn.
Huisuanzhang hauls in $80m
Undisclosed investors have supplied series D funding for the Tsinghua-backed bookkeeping and taxation software developer.
Mainspring Energy bounces to $95m series D
American Electric Power, Chevron and Equinor all participated in a round that increased the Stanford company’s total funding to $228m.
Exscientia erects $225m series D
Less than two months after closing a $100m series C round, the Durham spinout has raised $225m in a series D led by SoftBank Vision Fund 2.

Other News

SES seeks out corporates to raise $139m
General Motors led a series D round for the lithium-metal battery technology spinout of MIT formerly known as SolidEnergy Systems.
Lumicks leverages series D investors
Lumicks, which is developing single-molecule analysis technology based on research at Vrije Universiteit Amsterdam, has collected $93m.
SambaNova rams through $676m series D
The Stanford-linked artificial intelligence technology developer doubled its valuation to $5.1bn in a round led by SoftBank Vision Fund 2.
Inflammatix invites series D investors
D1 Capital Partners has led a $102m series D round for Inflammatix, whose existing shareholders include Stanford-StartX Fund.
Reflexion reconsiders series D round
Exploiting UChicago research, Reflexion is eyeing an expansion in Asia after receiving $40m in additional series D funding to bring the round to $150m.
Evolve BioSystems revolves to series D
UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.

Editor's Picks

Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
test reg

Login